COMMUNIQUÉS West-GlobeNewswire

HEXO becomes first cannabis company to join Food & Consumer Products of Canada
12/03/2019
GATINEAU, Quebec, March 12, 2019 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE-A: HEXO) is pleased to announce it is the first cannabis company to join Food & Consumer Products of Canada ( [...]
HEXO : première entreprise de cannabis à devenir membre de Produits alimentaires et de consommation du Canada
12/03/2019
GATINEAU, Québec, 12 mars 2019 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX: HEXO; NYSE-A : HEXO) a le plaisir d’annoncer qu’elle est la première entreprise de cannabis à adhérer à Produits [...]
Transactions in relation to share buyback program
12/03/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Aino Health AB (publ): Aino's HealthManager deployed for retail chain
12/03/2019
12 March 2019 Aino Health's SaaS solution HealthManager has been deployed for one of Finland's largest retail chains. It is a joint implementation project between the client and Aino Health, with 3,000 users. [...]
LIDDS: NanoZolid® technology presented at Pharma R&D congress in Paris
12/03/2019
Pharma R&D 2019 attracted a large number of academic and pharmaceutical industry delegates interested in finding new drug delivery technologies for drug products. LIDDS presented the NanoZolid® technology, its [...]
The pollen season kicks off with an award-winning pollen app
12/03/2019
If you are one of the estimated 5 million in the UK who sneeze and sniffle their way through the pollen season, then help is at hand. A personalised allergy app detailing location-based pollen counts and real-time air [...]
Bone Therapeutics appoints Olivier Godeaux as Chief Medical Officer and Benoit Moreaux as Chief Scientific and Technology Officer
12/03/2019
Press Release Gosselies, Belgium, 12 March 2019, 8am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, [...]
Bone Therapeutics annonce les nominationsd’Olivier Godeaux au poste de Chief Medical Officer et de Benoit Moreaux au poste de Chief Scientific and Technology Officer
12/03/2019
Communiqué de presse Gosselies, Belgique, le 12 mars 2019, 8h00 CET - BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE, éligible PEA-PME), société de thérapie cellulaire osseuse qui répond à d’importants besoins [...]
Biogen Enters Into an Agreement to Sell Its Large-Scale Biologics Manufacturing Site in Hillerød, Denmark to Fujifilm
12/03/2019
Approximately 800 employees at Hillerød site expected to continue employment under Fujifilm ownership Biogen will enter into manufacturing services agreements with Fujifilm to supply TYSABRI ® and third-party products [...]
Biocartis Group NV: Biocartis and Bristol-Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies
12/03/2019
PRESS RELEASE 12 March 2019, 07:00 CET Biocartis and Bristol-Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies Mechelen, Belgium, 12 March 2019 - Biocartis Group NV (the 'Company' [...]
Santhera Completes Patient Enrollment in Phase IV Long-term Study with Raxone® for the Treatment of Leber's Hereditary Optic Neuropathy
12/03/2019
Pratteln, Switzerland, March 12, 2019 - Santhera Pharmaceuticals (SIX: SANN) announces that it has completed patient enrollment in the ongoing Phase IV study (LEROS) with Raxone® (idebenone) for the treatment of Leber's [...]
Biophytis Reports Annual 2018 Financial Results and Provides Operational Update
12/03/2019
Clinical execution and advancement of our SARA program, including initiation of the SARA-INT Phase 2b clinical trial for sarcopenia Launch of our MYODA program for Duchenne muscular dystrophy (DMD) Expansion of [...]
Innate Pharma: Jennifer Butler appointed as Executive VP, General Manager, US
12/03/2019
Innate Pharma announces the appointment of Jennifer Butler as Executive Vice President, General Manager, US Commercial industry leader with immuno-oncology product launch experience joins Innate’s Executive Committee [...]
Innate Pharma: Jennifer Butler nommée VP exécutif, DG de la filiale américaine
12/03/2019
INNATE PHARMA ANNONCE LA NOMINATION DE JENNIFER BUTLER EN TANT QUE VICE-PRÉSIDENT EXECUTIF, DIRECTEUR GÉNÉRAL DE LA FILIALE AMÉRICAINE Un leader commercial du secteur avec de l’expérience dans les lancements de produits [...]
Guardant Health to Present at the 39th Annual Cowen Health Care Conference
12/03/2019
REDWOOD CITY, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, [...]
Guardant Health to Report Fourth Quarter and Full Year 2018 Financial Results on March 12, 2019
12/03/2019
REDWOOD CITY, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the fourth quarter and full year 2018 after market close on Tuesday, March [...]
Bhang Corporation Announces Official Sponsorship of ICBC Barcelona After-Party Featuring Damian Marley
12/03/2019
ICBC Barcelona will take place on March 14th, 2019 at the Auditori de Cornellà, with Bhang’s sponsored after-party at the W Barcelona Hotel LOS ANGELES, March 12, 2019 (GLOBE NEWSWIRE) -- Bhang Corporation ("Bhang" or [...]
Trillium Therapeutics Reports Annual Financial and Operating Results
11/03/2019
Positive data from the intratumoral trial of TTI-621, a CD47 immune checkpoint inhibitor, presented at the 2018 EORTC CLTF and ASH 2018 meetings Encouraging signals of activity and tolerability data from the intravenous [...]
ERYTECH Provides Business Update and Reports Financial Results for Full Year 2018
11/03/2019
Conference call and webcast on Tuesday, March 12 th at 1:30 pm CET/8:30 am EDT TRYbeCA1, a pivotal Phase 3 trial for eryaspase in second line pancreatic cancer, now actively enrolling patients TRYbeCA2, a proof of [...]

Pages